Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1998; 32:413-419
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lamich, R.
Right arrow Articles by Narula, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lamich, R.
Right arrow Articles by Narula, J.

Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transplantation

Rubén Lamicha, Manel Ballester, MDa, Vicens Martía, Vicens Brossaa, Rosa Aymata, Ignasi Carrió*, Lluis Bernà*, Marta Campreciósa, Mireia Puiga, Montserrat Estorch*, Albert Flotats*, Ramón Bordes{dagger}, Juan Garciaa, Josep M. Augèa, Josep M. Padróa, Josep M. Caralpsa and Jagat Narula{ddagger}

a Cardiomyopathy and Heart Transplantation Program, Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
* Service of Nuclear Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
{dagger} Department of Pathology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
{ddagger} Cardiac Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA



View larger version (73K):

[in a new window]
 
Figure 1 Angiographic evidence of early graft vasculopathy that responded to increased immunosuppressive therapy. Coronary angiography in left anterior oblique view in patient #1 demonstrated diffuse coronary artery disease 2 months after transplantation (A). The angiographic evidence of vasculopathy was also accompanied by anterior myocardial perfusion defect. The angiographic abnormality showed resolution with augmented immunosuppression. There was a complete resolution of scintigraphic perfusion abnormality. The patient continues to show angiographically normal coronary arteries 126 months after operation.

 


View larger version (150K):

[in a new window]
 
Figure 2 Histologic evidence of vasculitis. Endomyocardial biopsy specimen 1 month after heart transplantation in patient #10. A myocardial arteriole demonstrates evidence of vasculitis with intimal proliferation and edema almost obliterating the lumen (hematoxylin and eosin, x200). In addition to vasculitis, there was an evidence of ISHLT grade 3A parenchymal rejection (B). This patient demonstrated anterior myocardial perfusion abnormality in thallium perfusion scan. He was treated with increased immunosuppressive therapy with complete resolution of perfusion defect. This patient demonstrated normal coronary arteries at 34 months, when he died of a cerebrovascular accident.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement